Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

Tofacitinib helped a man with alopecia totalis regrow all his hair.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

The conclusion is that a new test was created to find substances that affect specific ion channels, and it works well for drug discovery.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

JAK inhibitors may become the first approved treatment for alopecia areata if they are proven safe and effective.

Tofacitinib helped regrow hair in a patient with severe hair loss and improved their quality of life without side effects.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

Ponatinib can cause a rare skin reaction that resolves with topical treatment and temporary drug discontinuation.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

Tofacitinib helped psoriasis but not alopecia universalis, needing more research.

Tridax procumbens is a versatile herb with many health benefits.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

A woman with severe hair loss saw significant hair regrowth after adding platelet-rich plasma injections to her treatment with tofacitinib.

A new compound shows promise as a topical treatment for hair loss.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Tirzepatide improved symptoms and hair regrowth in a man with folliculitis decalvans.

Oral tofacitinib can treat both psoriasis and alopecia universalis by normalizing inflammatory pathways.

Both treatments are similarly effective, but paclitaxel-carboplatin is cheaper and has more severe side effects.

Turpentine ointment is an effective and safe treatment for folliculitis.

Combining ATRA with TPO-RA effectively stabilizes platelet counts in ITP patients.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

Turpentine ointment is effective and safe for treating folliculitis.

Switching to generic tacrolimus was safe, effective, and saved money.

Triple therapy with clobetasol, hydroxychloroquine, and N-acetylcysteine is recommended for better outcomes in treating lichen planopilaris.

Co-trimoxazole may help treat autoimmune diseases.